Indian Journal of Respiratory Care

IJRC Email      Register      Login

VOLUME 8 , ISSUE 1 ( January-June, 2019 ) > List of Articles

Original Article

Prevalence of Type 2 Diabetes Mellitus in Chronic Obstructive Pulmonary Disease and Its Impact on the Severity of Chronic Obstructive Pulmonary Disease among Patients Attending Tertiary Care Center in Central Karnataka, Davangere

Eti Ajit, Kushal Bondade, J. Rakesh, Anup Banur, Priyadarshini Raykar

Keywords : Chronic obstructive pulmonary disease, diabetes mellitus, prevalence, screening

Citation Information : Ajit E, Bondade K, Rakesh J, Banur A, Raykar P. Prevalence of Type 2 Diabetes Mellitus in Chronic Obstructive Pulmonary Disease and Its Impact on the Severity of Chronic Obstructive Pulmonary Disease among Patients Attending Tertiary Care Center in Central Karnataka, Davangere. Indian J Respir Care 2019; 8 (1):42-45.

DOI: 10.4103/ijrc.ijrc_42_18

License: CC BY-NC-SA 4.0

Published Online: 05-12-2022

Copyright Statement:  Copyright © 2019; Indian Journal of Respiratory Care.


Introduction: Diabetes mellitus (DM) is an important and common comorbid condition associated with chronic obstructive pulmonary disease (COPD). The exact prevalence of DM in COPD patients among the Indian population is unknown. Coexisting DM is associated with poor outcome in COPD patients and has a significant impact on lung function and severity of the disease. Aim: The aim of this study was to determine the prevalence of type 2 DM in COPD patients attending tertiary care hospital and to assess its impact on the severity of the disease and exacerbation. Patients and Methods: A cross-sectional study was done at a tertiary care center in Davangere from July to December 2016. Convenience sampling was used to study 412 patients attending the hospital for consultation. An interview schedule consisting of sociodemographic details and GOLD criteria 2015 to diagnose COPD and the World Health Organization criteria for DM was used. Results: The prevalence of DM was 23.05% (95) among 412 COPD patients studied. Thirty-five (8.49%) patients were newly diagnosed with DM. The prevalence in mild, moderate, severe, and very severe COPD was 14.73%, 18.94%, 36.84%, and 29.47%, respectively. DM group patients had a significant decline in lung function compared to non-DM group (mean forced expiratory volume 1% - 45.92 ± 4.22 v/s 56.64 ± 3.58, P = 0.001), and the majority of patients with DM (29.47%) were in exacerbation when compared to nonDM group (16.71%). Conclusion: The prevalence of DM is high in COPD patients, and significant numbers are newly detected. Hence, it is crucial to screen all COPD patients for DM routinely. Further diabetics tend to have more severe COPD when compared to nondiabetics.

  1. COPD Predicted to be Third Leading Cause of Death in 2030. Available from: [Last accessed on 2015 Aug 22].
  2. World Health Organization. Burden of COPD. Available from: [Last accessed on 2017 Jan 12].
  3. Claire EW and Emma HB. Metabolic syndrome and diabetes mellitus in COPD. In: Klaus FR, Jadwiga AW, Emiel FM. Editor. European Respiratory Mongraph. Vol. 59. 2013. p. 117-34.
  4. Salvi S, Agrawal A. India needs a national COPD prevention and control programme. J Assoc Physicians India 2012;60:5-7.
  5. Joshi SR, Parikh RM. India - Diabetes capital of the world: Now heading towards hypertension. J Assoc Physicians India 2007;55:323-4.
  6. Mahishale V, Mahishale A, Patil B, Sindhuri A, Eti A. Screening for diabetes mellitus in patients with chronic obstructive pulmonary disease in tertiary care hospital in India. Niger Med J 2015;56:122-5.
  7. Baker EH, Janaway CH, Philips BJ, Brennan AL, Baines DL, Wood DM, et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax 2006;61:284-9.
  8. Chakrabarti B, Angus RM, Agarwal S, Lane S, Calverley PM. Hyperglycaemia as a predictor of outcome during non-invasive ventilation in decompensated COPD. Thorax 2009;64:857-62.
  9. Moretti M, Cilione C, Tampieri A, Fracchia C, Marchioni A, Nava S, et al. Incidence and causes of non-invasive mechanical ventilation failure after initial success. Thorax 2000;55:819-25.
  10. Rana JS, Mittleman MA, Sheikh J. Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women. Diabetes Care 2004;27:2478-84.
  11. Feary JR, Rodrigues LC, Smith CJ, Hubbard RB, Gibson JE. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: A comprehensive analysis using data from primary care. Thorax 2010;65:956-62.
  12. McKeever TM, Weston PJ, Hubbard R, Fogarty A. Lung function and glucose metabolism: An analysis of data from the third national health and nutrition examination survey. Am J Epidemiol 2005;161:546-56.
  13. Davis TM, Knuiman M, Kendall P, Vu H, Davis WA. Reduced pulmonary function and its associations in type 2 diabetes: The Fremantle Diabetes Study. Diabetes Res Clin Pract 2000;50:153-9.
  14. El-Habashy MM, Agha MA, El-Basuni HA. Impact of diabetes mellitus and its control on pulmonary functions and cardiopulmonary exercise tests. Egypt J Chest Dis Tuberc 2014;63:471-6.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.